Concord Medical Services Holdings Limited (NYSE:CCM) Short Interest Up 63.3% in August

Concord Medical Services Holdings Limited (NYSE:CCM) was the target of a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 7,578 shares, a growth of 63.3% from the July 30th total of 4,641 shares. Approximately 0.3% of the company’s stock are short sold. Based on an average daily volume of 117,289 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analyst Weigh In

CCM has been the subject of several research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Concord Medical Services in a research report on Friday, August 21st. Wall Street Zen raised shares of Concord Medical Services to a “hold” rating in a report on Saturday, August 15th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has an average rating of “Sell”.

Concord Medical Services Price Performance

Shares of NYSE CCM traded up $0.08 during trading hours on Tuesday, hitting $4.64. 133,066 shares of the stock were exchanged, compared to its average volume of 40,819. Concord Medical Services has a 12 month low of $3.18 and a 12 month high of $6.98. The firm has a fifty day moving average price of $4.62 and a 200-day moving average price of $4.35. The company has a current ratio of 0.48, a quick ratio of 0.46 and a debt-to-equity ratio of 1.33.

About Concord Medical Services

Concord Medical Services Holdings Limited is one of China’s leading providers of radiotherapy equipment and oncology services. The company specializes in supplying and operating advanced radiotherapy machines, including linear accelerators, computed tomography (CT) simulators and brachytherapy units, to public and private hospitals. Through its integrated service model, Concord Medical Services delivers treatment planning, machine maintenance and clinical support to enhance the precision and effectiveness of cancer therapies.

Founded in 1997 and headquartered in Beijing, Concord Medical Services has developed an extensive network of oncology centers across major cities and provinces in China.